Canopy Biosciences COVID-19 Immune Response Assay
Canopy Biosciences, a Bruker company, has launched the research-use-only COVID-19 Immune Response Assay for use on Canopy's ZellScannerOne spatial phenotyping instrument. ZellScannerOne enables multiplexed spatial quantification of protein biomarkers in tissue samples and suspended cells. The new assay can spatially profile 18 different protein biomarkers, and the data it generates enables the identification and quantification of 32 distinct cellular phenotypes, including major immune cell types and various cell states. Canopy said the assay will be available initially as a service, with a reagent kit to follow at a later date.